BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2003
View Archived Issues
R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Isis Pharmaceuticals
Read More
R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Proneuron
Read More
Improved motor response found with CP-101606 in hemiparkinsonian rats
Read More
HP-184 improves hindlimb movement and myelination in rats with spinal cord injury
Read More
Subjective improvement in spasticity associated with cannabinoids in multiple sclerosis
Read More
Kalypsys and CV Therapeutics collaborate on cardiovascular disease
Read More
Boehringer Ingelheim exercises therapeutic antibody option
Read More
R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Ortec
Read More
R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Oncolytics Biotech
Read More
Prevacid NapraPAC receives FDA approval
Read More
Good tolerability profile for OSI-461 in advanced cancer patients
Read More
FTY-720 exerts selective antitumor effects on hepatoma cell lines
Read More
New immunosuppressants and their therapeutic use reported by Sankyo
Read More
Novel TLR modulators with utility in sepsis developed at Mochida
Read More
New prostanoid EP4 antagonists under study at Pfizer
Read More
Merck presents new GABA(A) ligands for anxiety, convulsions, etc.
Read More
New phthalocyanine-based photosensitizers designed by Nihon U. scientists
Read More
AstraZeneca presents three related series of alpha7 nAChR agonists
Read More
New antifungal azoles prepared and tested at Ranbaxy
Read More
Chugai claims new antiestrogens that inhibit osteoclast differentiation
Read More
Novel HDAC inhibitors identified at AstraZeneca
Read More
Allergan completes Oculex acquisition
Read More
BioMS submits Canadian pre-CTA package for MBP-8298
Read More
Celltech completes integration of OGS
Read More
Phase I/II study evaluates Advexin oral rinse for oral premalignancies
Read More
Encouraging preliminary results from rat carcinogenicity study of Preos
Read More
Promising preliminary phase I data for HER-2 Protein AutoVac vaccine
Read More
SkyePharma seeks U.K. approval of DepoMorphine
Read More
Canadian CTA filed for Tectin in refractory severe chronic pain
Read More